One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

If management's predictions are accurate, the company is in for a period of sustained growth.

Nvidia has built a solid position for itself in this fast-growing data center niche that could help generate sizable revenue ...

New York Community Bancorp isn't realistically poised for sudden and dramatic improvement. The bank expanded too quickly in ...

Intel stock closed up 3.3% on the news, after jumping as much as 9.5% when the story first broke. Qualcomm closed down 2.9% ...

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial integrity ensures our experts’ opinions aren’t influenced by compensation. Terms ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The pet specialist's largest shareholder is selling a large chunk of stock. It priced this at below Chewy's latest closing ...

UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus ...

Yet its foundry business has shown potential for improvement. Intel will turn that business into a separate subsidiary, ...

Initial public offerings (IPOs) can be great opportunities for investors. After all, getting in on a stock on the ground floo ...